Both HDAC5 and HDAC6 are required for the proliferation and metastasis of melanoma cells

Histone deacetylase 5 HDAC6 Vorinostat
DOI: 10.1186/s12967-015-0753-0 Publication Date: 2016-01-08T12:56:43Z
ABSTRACT
Histone deacetylase (HDAC) inhibitors are widely used in clinical investigation as novel drug targets. For example, panobinostat and vorinostat have been to treat patients with melanoma. However, HDAC small-molecule compounds without a specific target, their mechanism of action is unclear. Therefore, it necessary investigate which HDACs required for the proliferation metastasis melanoma cells. We overexpression knocking down lentivirus clarify influence HDAC5 HDAC6 development. Also, we introduced stable or knockdown cells into null mice found that were unable form solid tumors. Finally, tested expression sub-location tissues tumor adjacent tissues. In this study, highly expressed but exhibited low levels normal skin Furthermore, knocked A375 demonstrated both contributed This study cell through different signaling pathways.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (54)
CITATIONS (56)